| |
ATC |
 1 Agents affecting nervous system and sensory organs
|
|
|
 2 Agents affecting individual organs
|
21 Cardiovascular agents
|
22 Respiratory organ agents
|
23 Digestive organ agents
|
24 Hormones
|
25 Urogenital and anal organ agents
|
251 Urinary organ agents
|
252 Genital organ agents
|
253 Oxytocics
|
254 Contraceptives
|
255 Hemorrhoidal preparations
|
259 Miscellaneous
|
2590 Miscellaneous
|
 D01333 Urapidil (JP17/INN)
D01263 Ritodrine hydrochloride (JP17/USP)
D00718 Flavoxate hydrochloride (JP17/USAN)
D00722 Oxybutynin chloride (USP); Oxybutynin hydrochloride (JAN)
D01007 Propiverine hydrochloride (JP17)
D01148 Tolterodine tartrate (JAN/USAN)
D01269 Solifenacin succinate (JAN/USAN/INN)
D08923 Fesoterodine fumarate (JAN/USP)
D09535 Mirabegron (USAN/JAN)
D02229 Sildenafil citrate (JAN/USAN)
D02008 Tadalafil (JAN/USAN/INN)
D03260 Vardenafil hydrochloride hydrate (JAN)
D01024 Tamsulosin hydrochloride (JP17/USAN)
D01965 Silodosin (JP17/INN)
D01360 Clenbuterol hydrochloride (JAN/USP)
D01674 Naftopidil (JP17/INN); Naftopidil tablets (JP17); Naftopidil orally disintegrating tablets (JP17)
D02019 Magnesium sulfate hydrate - glucose mixt
D04711 Cernitin pollen extract (JAN)
D04712 Quercus salicina extract (non-JP)
D06273 Imidafenacin (JAN/INN)
D08712 Chimaphila umbellata - populus tremula - pulsatilla pratensis mill - equisetum arvense - wheat germ oil mixt
|
C02CA06
G02CA01
G04BD02
G04BD04
G04BD06
G04BD07
G04BD08
G04BD11
G04BD12
G04BE03
G04BE08
G04BE09
G04CA02
G04CA04
R03AC14 R03CC13
|
26 Epidermides
|
27 Dental preparations
|
29 Other agents affecting individual organs
|
|
|
3 Agents affecting metabolism
|
|
|
4 Agents affecting cellular function
|
|
|
5 Crude drugs and Chinese medicine formulations
|
|
|
6 Agents against pathologic organisms and parasites
|
|
|
7 Agents not mainly for therapeutic purpose
|
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan